Makrigiannis Stamatios Cardiologist
Education & Academic Qualifications
- National and Kapodistrian University of Athens, Medical Degree (1999)
- National and Kapodistrian University of Athens, PhD (2013)
- Interventional Cardiology Training (educational grant from the Hellenic Cardiological Society)
- Intensive Care Medicine
“Prognostic value of C-reactive protein in patients submitted to reperfusion due to myocardial infarction”
Member of the Hellenic Cardiological Society (HCS)
Member of the European Society of Cardiology (ESC)
Member of the European Association of Percutaneous Cardiovascular Interventions
Member of the Acute Cardiovascular Care Association
Member of the Hellenic Medical Society for the Study of Risk Factors in Cardiovascular Disease
Member of the Working group of Haemodynamic and Interventional Cardiology of the HSC
Member of the Working group of Prevention and Rehabilitation of the HSC
AD-HOC REVIEWER for peer-reviewed international journals
American Journal of Cardiology
Journal of Critical Care
1st Cardiology Department, HYGEIA Hospital (since 2013)
Intensive Care Unit, “ΤΖΑΝΕΙΟ” General Hospital of Piraeus (2011-2013)
Cardiology Department, “ΤΖΑΝΕΙΟ” General Hospital of Piraeus (2006 – 2010)
1st Department of Internal Medicine, “ΜΕΤΑXΑ” Hospital of Piraeus (2002-2004)
Clinical and Research Interest
Invasive treatment of coronary artery disease, especially using radial approach
Acute and intensive cardiac care
Antithrombotic treatment in atrial fibrillation and acute coronary syndromes
Pathophysiologic mechanisms in coronary artery disease
Optimization of transradial techniques in percutaneous interventions
Biomarkers in acute coronary syndromes
Antithrombotic treatment in atrial fibrillation
Educational grant from the Hellenic Cardiological Society, 2013
Moderated poster award “Dabigatran plasma concentration measurement in patients with AF: is it helpful for choosing the optimal dose?” Panhellenic Congress of Cardiology, Thessaloniki 2015.
Research protocol funding, Hellenic Cardiological Society, 2014.
Original research award “Clinical significance of different hsCRP measurements in the course of ST-elevation myocardial infarction” Panhellenic Congress of Cardiology, Athens 2013.
Research protocol funding, Hellenic Cardiological Society, 2013.
Original research award “C-reactive protein kinetics patients with ST-elevation acute myocardial infarction” HCS Working group seminars, Thessaloniki 2012.
Original research award “Characteristics of nonagenarians in Attica” HCS Working group seminars, Thessaloniki 2012.
“Non ST-segment elevation Acute Coronary Syndromes”. Book Chapter in “Καρδιολογικά Προβλήματα στην Κλινική Πράξη” [Challenges in Clinical Practice -in Greek] G.B Parisianos Medical Publications 2010. ISBN 978-960-99126-6-2
“Atheromatous plaque – Diagnostic approach of the vulnerable plaque”. Book Chapter in “Καρδιομεταβολικός Κίνδυνος” [Cardiometabolic risk -in Greek] G.B Parisianos Medical Publications 2007. ISBN 978-960-89486-2-4
“Introduction to the Cardiological Electronic Patient Record” In.Ι.Ε.S.Α.P Scientific Publications 2006. ISBN 960-89043-0-7
Gastrointestinal bleeding in patients receiving antiplatelet and anticoagulant therapy: practical guidance for restarting therapy and avoiding recurrences. Hellenic J Cardiol 2014;55:499-509.
Incidence and predictors of new-onset atrial fibrillation in noncardiac intensive care unit patients. J Crit Care 2014;29:697.e1-5.
Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acute myocardial infarction. Am J Cardiol 2013;111: 26-30.
Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure. Heart 2012;98:860-4.
Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure. Int J Cardiol 2010;141:284-90.
The impact of right ventricular involvement on the postdischarge long-term mortality in patients with acute inferior ST-segment elevation myocardial infarction. Angiology 2010;61:179-83.
The impact of aspirin resistance on the long-term cardiovascular mortality in patients with non-ST segment elevation acute coronary syndromes. Clin Cardiol 2009;32:142-7.
The impact of oral antiplatelet responsiveness on the long-term prognosis after coronary stenting. Am Heart J 2007;154:676-81.
The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes. Int J Cardiol 2008;124:312-8.
The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction. Heart 2007; 93:952-6